| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Erickson Gayn | President and CEO, Director | C/O AEHR TEST SYSTEMS, 400 KATO TERRACE, FREMONT | /s/Chris Siu, Attorney-in-Fact | 14 Oct 2025 | 0001364097 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AEHR | Common Stock | Tax liability | $96,746 | -3,791 | -1.4% | $25.52 | 265,362 | 13 Oct 2025 | Direct | F1, F2 |
| transaction | AEHR | Common Stock | Tax liability | $94,096 | -3,448 | -1.3% | $27.29 | 261,914 | 14 Oct 2025 | Direct | F1, F2 |
| holding | AEHR | Common Stock | 291,628 | 13 Oct 2025 | By Trust | F3 |
| Id | Content |
|---|---|
| F1 | Represents shares that were withheld to satisfy tax withholding obligations upon vesting of restricted stock units and restricted shares. This does not represent a sale by the Reporting Person. |
| F2 | The amount reported includes shares subject to unvested restricted stock units and unvested restricted shares. |
| F3 | RSA with vesting schedule |